A research team led by scientists at Baylor College of Medicine and Texas Children's Hospital has developed a new approach called nano-radiomics that uses complex analyses of imaging data to assess changes in the tumor microenvironment that cannot be detected with conventional imaging methods. Nano-radiomics combines imaging technology using a nanoparticle contrast agent, with radiomics for computational mining of 3D imaging data. This approach provides the promise of a new noninvasive means to enhance current imaging methods in measuring and monitoring the effectiveness of cellular immunotherapies designed to specifically target the tumor microenvironment.
An official website of the United States government.